UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
55 hedge funds and large institutions have $258M invested in Unity Biotechnology in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.73% more ownership
Funds ownership: 3.01% → 3.74% (+0.73%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
55
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$20M | |
| 2 | +$6.61M | |
| 3 | +$5.65M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.19M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.83M |
Top Sellers
| 1 | -$9.9M | |
| 2 | -$815K | |
| 3 | -$666K | |
| 4 |
Morgan Stanley
New York
|
-$634K |
| 5 |
D.E. Shaw & Co
New York
|
-$183K |